Lourdes Felix
Chief Executive Officer at BIOCORRX INC.
Net worth: 117 791 $ as of 2024-04-29
Profile
Lourdes Felix is the founder of BioCorRx Pharmaceuticals, Inc. She currently holds multiple positions as an Independent Director in various companies including Siyata Mobile, Inc., Lichen China Ltd., Vocodia Holdings Corp., Avalon GloboCare Corp., and La Rosa Holdings Corp.
Additionally, she serves as the Director, CFO, Chief Executive & Operating Officer at BioCorRx, Inc. Ms. Felix completed her undergraduate degree at the University of Phoenix in 2005 and holds an MBA from D'Amore-Mckim School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOCORRX, INC.
0.91% | 2024-03-27 | 80,395 ( 0.91% ) | 70 346 $ | 2024-04-29 |
BIOCORRX, INC.
25.00% | 2024-03-24 | 40,000 ( 25.00% ) | 35 000 $ | 2024-04-29 |
BIOCORRX, INC.
12.50% | 2024-03-24 | 10,000 ( 12.50% ) | 8 750 $ | 2024-04-29 |
| 2024-04-03 | 2,500 ( 0.01% ) | 2 750 $ | 2024-04-29 | |
Vocodia Holdings Corp.
 Vocodia Holdings Corp. Packaged SoftwareTechnology Services Vocodia Holdings Corp. engages in the provision of conversational artificial intelligence technology. The firm is also involved in building practical artificial intelligence functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. The company was founded by Brian Podolak and James Sposato on April 27, 2021 and is headquartered in Boca Raton, FL. 0.06% | 2024-02-13 | 5,000 ( 0.06% ) | 945 $ | 2024-04-29 |
AVALON GLOBOCARE CORP.
-.--% | 2024-03-28 | 0 ( -.--% ) | - $ | 2024-04-29 |
Lourdes Felix active positions
| Companies | Position | Start |
|---|---|---|
| BIOCORRX INC. | Chief Executive Officer | 2020-11-08 |
| SIYATA MOBILE INC. | Director/Board Member | 2021-10-28 |
| LICHEN CHINA LIMITED | Director/Board Member | - |
| AVALON GLOBOCARE CORP. | Director/Board Member | 2023-01-08 |
| LA ROSA HOLDINGS CORP. | Director/Board Member | 2024-04-18 |
BioCorRx Pharmaceuticals, Inc.
 BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Founder | - |
Vocodia Holdings Corp.
Vocodia Holdings Corp. Packaged SoftwareTechnology Services Vocodia Holdings Corp. engages in the provision of conversational artificial intelligence technology. The firm is also involved in building practical artificial intelligence functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. The company was founded by Brian Podolak and James Sposato on April 27, 2021 and is headquartered in Boca Raton, FL. | Director/Board Member | 2024-02-21 |
Training of Lourdes Felix
| University of Phoenix | Undergraduate Degree |
| D'Amore-Mckim School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| BIOCORRX INC. | Health Services |
| AVALON GLOBOCARE CORP. | Health Technology |
| SIYATA MOBILE INC. | Electronic Technology |
| LICHEN CHINA LIMITED | Commercial Services |
 | Technology Services |
| LA ROSA HOLDINGS CORP. | Finance |
| Private companies | 1 |
|---|---|
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
- Stock Market
- Insiders
- Lourdes Felix
